Study of Hemodynamic Conditions Measured During Hepatectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

9 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-08

Study Completion Date

2019-03-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hepatocellular insufficiency is a dreaded complication after hepatectomy, since, if it is persistent, it leads to the death of the patient in the absence of liver transplantation.

The preoperative evaluation aims in particular to estimate the risk of postoperative hepatocellular insufficiency so as to minimize or contraindicate high-risk patients.

It has been shown that the flow of the portal vein is correlated with liver function, especially in the living donor and after portal embolization. More recently, the study of flow rates in the portal vein and the hepatic artery after transplantation has shown a correlation with the recovery of graft function.

The hypothesis is that portal and arterial flow after hepatectomy can predict postoperative hepatocellular function.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

NCT05339984

Liver Diseases Liver Transplantation

RECRUITING NA

Hepato Biliary Scintigraphy to Assess the Risk of Postoperative Liver Failure Hepatectomies

NCT02753517

Hepatic Insufficiency

TERMINATED NA

Transient Elastography in Hepatectomy for Hepatocellular Carcinoma

NCT01441453

Surgery Hepatocellular Carcinoma

UNKNOWN NA

Paracetamol Metabolism Research in Postoperative Hepatic Surgery

NCT03297073

Paracetamol Causing Adverse Effects in Therapeutic Use Hepatic Disease

COMPLETED NA

Interest of Oxygenated Hypothermic Perfusion (PHO) in Preservation of Hepatic Grafts From Expanded Criteria Donors

NCT03376074

Hepatocellular Injury

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Measurements of flow rates in the portal vein and the hepatic artery by different transit times are available thanks to the Medistim VeriQTM system that the investigators already use routinely in the context of liver transplantation when performing hepatectomies.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Dysfunction Circulatory; Change

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hepatectomy

Patient undergoing laparotomy for liver resection. The aim is to measure the flow rates in the portal vein and the hepatic artery.

Liver debit measure

Intervention Type PROCEDURE

Mesure of liver debit during hepatectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Liver debit measure

Mesure of liver debit during hepatectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patient 18 years or more
* Patient undergoing laparotomy for liver resection

Exclusion Criteria

* Patient under tutorship or curatorship
* Pregnant or lactating woman
* Difficulties in understanding French
* Patient operated by laparoscopy
* Patient having objected to the processing of his data

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No